efavirenz has been researched along with AIDS Seroconversion in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (27.78) | 29.6817 |
2010's | 24 (66.67) | 24.3611 |
2020's | 2 (5.56) | 2.80 |
Authors | Studies |
---|---|
Chunrong, L; Huanxia, L; Ke, Y; Lin, C; Ruifeng, Z; Shenghua, H; Tongtong, Y; Xiaojing, Y; Yin, W; Yuan, Y; Yuanhong, H | 1 |
Abdool Karim, Q; Dawood, H; Mansoor, LE; Matten, D; Naicker, CL; Naidoo, K; Singo, D; Williamson, C | 1 |
Chang, SC; Chang, SY; Chiang, C; Hsiao, CF; Huang, SH; Hung, CC; Lin, SW; Lin, YT; Liu, WC; Su, YC; Sun, HY | 1 |
Balestre, E; Bärnighausen, T; Bazin, B; Boyer, S; Dabis, F; De Oliveira, T; Dreyer, J; Herbst, K; Iwuji, CC; Larmarange, J; Makowa, T; McGrath, N; Newell, ML; Okesola, N; Orne-Gliemann, J; Pillay, D; Rekacewicz, C; Tanser, F; Thiebaut, R | 1 |
Afonso, C; Arenas-Pinto, A; Brouwers, P; Chasanov, WM; Collins, S; Cooper, DA; Cummins, N; Flynn, PM; Fox, J; Grund, B; Katlama, C; Kedem, E; Klingman, KL; Martinez, E; Sedlacek, D; Sharma, S; Sierra-Madero, J | 1 |
Gupta, SK; Haneline, LS; Liu, Z; Repass, MJ; Sims, EC; Yoder, MC | 1 |
Abebo, TA; Altaye, AA; Asfaw, FT; Bekele, FB; Hibistu, DT; Kebede, HG; Laelago, T; Lukas, K; Tesfaye, DJ; Turuse, EA | 1 |
Bacchetti, P; Chandy, S; Devi, S; Ekstrand, ML; Gandhi, M; Heylen, E; Kumar, R; Kuncze, K; Kurpad, AV; Okochi, H; Phung, N | 1 |
Hills-Nieminen, C; Tseng, A | 1 |
Abgrall, S; Antinori, A; Cavassini, M; Costagliola, D; Crane, HM; Gill, MJ; Gomez Sirvent, JL; Guest, JL; Ingle, SM; Manzardo, C; May, MT; Mercie, P; Mugavero, MJ; Phillips, A; Reekie, J; Reiss, P; Saag, MS; Samji, H; Stephan, C; Sterling, TR; Sterne, JA; Tate, J; Wasmuth, JC | 1 |
Crowe, SM; David, M; Gare, J; Hearps, AC; Imara, U; Kaima, P; Kelly-Hanku, A; Kombati, Z; Ryan, CE; Siba, PM; Timbi, D | 1 |
Badley, AD; Boyd, MA; Chu, H; Cummins, NW; Khoo, S; Neaton, J; Neuhaus, J; Rockstroh, JK; Rotger, M; Skiest, DJ; Telenti, A; Weinshilboum, R; Wyen, C | 1 |
Hauptfleisch, MP; Moore, DP; Rodda, JL | 1 |
Appleby, T; Bradshaw, D; Gilleece, Y; Grimes, R; Pinto-Sander, N; Sahabandu, T; Stein, P; Stockwell, S | 1 |
Abgrall, S; Bucher, H; Cain, LE; Caniglia, EC; Casabona, J; Costagliola, D; Dabis, F; Esteve, A; Fehr, J; Hernán, MA; Jarrín, I; Jose, S; Justice, A; Logan, R; Meyer, L; Muga, R; Olson, A; Paparizos, V; Pérez-Hoyos, S; Phillips, A; Reiss, P; Robins, J; Rubio, R; Sabin, C; Seng, R; Sterne, JAC; Tate, J; Touloumi, G; van Sighem, A; Vandenhende, MA | 1 |
Alioni, S; Izudi, J; Kerukadho, E; Ndungutse, D | 1 |
Asari, V; Baxter, C; Garrett, N; Grobler, A; Karim, QA; Karim, SSA; Majola, N; Naicker, N; Naidoo, A; Werner, L | 1 |
Asselman, V; Boulle, A; Marais, S; Meintjes, G; Pepper, DJ; Thienemann, F; Wilkinson, RJ | 1 |
Dia, AT; Diallo, PD; Gaye, AM; Sow, PG | 1 |
Donnelly, J | 1 |
Chandy, S; Ekstrand, M; Heylen, E; Vallabhaneni, S | 1 |
Abgrall, S; Bansi, L; Bucher, HC; Cain, LE; Casabona, J; Costagliola, D; de Wolf, F; del Amo, J; Elzi, L; Esteve, A; Hernán, MA; Justice, A; Lodi, S; Logan, R; Meyer, L; Moreno, S; Muga, R; Pérez-Hoyos, S; Phillips, A; Robins, JM; Sabin, C; Seng, R; Sterne, JA; Tate, J; Touloumi, G; van Sighem, A; Vourli, G | 1 |
Anderson, AM; Chane, T; Chen, S; Easley, KA; Patel, M; Xue, W | 1 |
Dabaghzadeh, F; Dashti-Khavidaki, S; Ghaeli, P; Khalili, H | 1 |
Bissek, AC; Defo, D; Kouotou, EA; Mboua, JB | 1 |
Carro, JA; Cuevas, MJ; Martín, V; Mostaza, JL; Ortega, L; Pérez-Simón, MR | 1 |
Cuadros, Y; Edelstein, HE | 1 |
Ananworanich, J; Cardiello, P; Chan, J; Cooper, DA; Duncombe, C; Lange, J; Moor, Z; Phanuphak, P; Ruxrungtham, K; Siangphoe, U | 1 |
Corrigan, GE; Crowe, SM; Dunne, AL; Greengrass, VL; Hocking, J; Tachedjian, G; Turnbull, SP | 1 |
Biollaz, J; Bleiber, G; Buclin, T; Colombo, S; Décosterd, L; Furrer, H; Keiser, O; Lee, BL; Rotger, M; Telenti, A | 1 |
Arici, C; Carosi, G; Ladisa, N; Maggiolo, F; Minoli, L; Orani, AM; Paraninfo, G; Patroni, A; Pierotti, P; Sighinolfi, L; Suter, F; Tinelli, C; Torti, C | 1 |
Amin, J; Cooper, DA; Emery, S; Hales, G; Winston, A | 1 |
Anastos, K; Cohen, M; Cole, S; Hessol, NA; Justman, J; Kaplan, RC; Lu, D; Shi, Q; Tien, PC; Vigen, C; Young, M | 1 |
Ahmad, RS; Gazzard, BG; King, DM; Morlese, JF; Nelson, MR; Qazi, NA | 1 |
Knowles, SR; Kuriakose, B; Phillips, EJ | 1 |
2 review(s) available for efavirenz and AIDS Seroconversion
Article | Year |
---|---|
Drug interactions between antiretrovirals and hormonal contraceptives.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Drug Interactions; Female; HIV Seropositivity; Humans; Medroxyprogesterone Acetate; Nevirapine; Pregnancy; Pregnancy, Unplanned; Protease Inhibitors; Ritonavir | 2013 |
Potential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Cyproheptadine; Drug Interactions; Evidence-Based Medicine; HIV Seropositivity; Humans; Neurotoxicity Syndromes; Serotonin 5-HT2 Receptor Antagonists | 2012 |
4 trial(s) available for efavirenz and AIDS Seroconversion
Article | Year |
---|---|
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Emtricitabine; Female; HIV Infections; HIV Seropositivity; Humans; Incidence; Male; Mass Screening; Middle Aged; Research Design; South Africa; Tenofovir; Treatment Outcome; Young Adult | 2018 |
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV Infections; HIV Seropositivity; Humans; Male; Middle Aged; Self-Injurious Behavior; Suicide; Viral Load | 2018 |
Efficacy and safety of tenofovir-containing antiretroviral therapy in women who acquired HIV while enrolled in tenofovir gel prophylaxis trials.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Emtricitabine; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Patient Safety; Pregnancy; Primary Prevention; RNA, Viral; South Africa; Tenofovir; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Viral Load; Zidovudine | 2017 |
Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs.
Topics: Adult; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Exanthema; Female; HIV Seropositivity; Humans; Incidence; Male; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Risk Factors; Thailand; Treatment Outcome | 2005 |
30 other study(ies) available for efavirenz and AIDS Seroconversion
Article | Year |
---|---|
Effectiveness and Safety of Dolutegravir Versus Efavirenz-Based Antiviral Regimen in People Living With HIV-1 in Sichuan Province of China: A Real-World Study.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Oxazines; Piperazines; Pyridones; Retrospective Studies | 2022 |
Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South Africa.
Topics: Administration, Oral; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Resistance, Viral; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Epidemics; Female; HIV Seropositivity; HIV-1; Humans; Lamivudine; Pre-Exposure Prophylaxis; Retrospective Studies; South Africa; Treatment Outcome; Viral Load; Young Adult; Zidovudine | 2020 |
Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Female; Genotype; HIV Infections; HIV Seropositivity; Humans; Male; Polymorphism, Single Nucleotide; Young Adult | 2017 |
Endothelial Colony-Forming Cell Function Is Reduced During HIV Infection.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cell Proliferation; Chemokine CCL5; Cyclopropanes; Endothelium; Female; Fetal Blood; Flow Cytometry; GPI-Linked Proteins; HIV Seronegativity; HIV Seropositivity; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Neovascularization, Physiologic; Plasma; Prospective Studies; Receptors, IgG; Stem Cells; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in Southern Ethiopia.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Developing Countries; Directive Counseling; Drug Therapy, Combination; Ethiopia; Female; Health Services Accessibility; HIV Seropositivity; Hospitals, Public; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Medication Adherence; Pregnancy; Prenatal Care; Surveys and Questionnaires; Tenofovir; Time Factors; Travel; Young Adult | 2019 |
Measuring Adherence to Antiretroviral Therapy via Hair Concentrations in India.
Topics: Adolescent; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; Hair; HIV Seropositivity; Humans; India; Male; Medication Adherence; Nevirapine; San Francisco; Self Report; Young Adult | 2019 |
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009.
Topics: Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Europe; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lopinavir; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir; Time Factors; United States | 2013 |
Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dried Blood Spot Testing; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Papua New Guinea; Reverse Transcriptase Inhibitors; Stavudine; Treatment Failure; Viral Load; Young Adult; Zidovudine | 2014 |
Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Ethnicity; Female; Genetic Predisposition to Disease; HIV Seropositivity; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Risk Factors; Switzerland; Treatment Outcome; Withholding Treatment | 2015 |
Efavirenz as a cause of ataxia in children.
Topics: Adolescent; Alkynes; Anti-HIV Agents; Ataxia; Benzoxazines; Child; Cyclopropanes; Female; HIV Infections; HIV Seropositivity; Humans | 2015 |
A case of hereditary coproporphyria precipitated by efavirenz.
Topics: Abdominal Pain; Adult; Alkynes; Benzoxazines; Coproporphyria, Hereditary; Cyclopropanes; HIV Seropositivity; HIV-1; Humans; Male; Porphobilinogen; Reverse Transcriptase Inhibitors | 2016 |
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals.
Topics: Adult; Alkynes; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dose-Response Relationship, Drug; Europe; Female; Follow-Up Studies; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; United States; Viral Load | 2016 |
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Weight; CD4-Positive T-Lymphocytes; Cohort Studies; Cyclopropanes; Disclosure; Female; HIV Infections; HIV Seropositivity; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Nevirapine; Retrospective Studies; Tenofovir; Treatment Outcome; Uganda | 2016 |
Central nervous system disorders after starting antiretroviral therapy in South Africa.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV Seropositivity; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Middle Aged; Prospective Studies; South Africa; Young Adult | 2010 |
[Comparative study of two anti-antiretroviral protocols used for treatment of a cohort of HIV 1-positive patients followed at the Institute of Public Health and Hygiene in Dakar, Senegal].
Topics: Academies and Institutes; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; HIV Seropositivity; HIV-1; Humans; Hygiene; Lamivudine; Nevirapine; Public Health; Quality of Life; Retrospective Studies; Senegal; Survival Analysis; Treatment Outcome; Zidovudine | 2011 |
HIV/AIDS and the road to Rome.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Clinical Trials, Phase III as Topic; Congresses as Topic; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV Seropositivity; Humans; Malawi; Male; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Public Health; Pyrimidines; Randomized Controlled Trials as Topic; Rilpivirine; Sexual Behavior; Sexual Partners; South Africa; Stereotyping; Treatment Outcome | 2011 |
Battles with donors cloud Malawi's HIV prevention plan.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Charities; Cyclopropanes; Drug Costs; Drug Therapy, Combination; Female; Health Policy; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; International Cooperation; Lamivudine; Malawi; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2011 |
Reasons for and correlates of antiretroviral treatment interruptions in a cohort of patients from public and private clinics in southern India.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Delivery of Health Care; Female; HIV Seropositivity; HIV-1; Humans; India; Male; Medication Adherence; Nevirapine; Private Sector; Prospective Studies; Public Sector; Surveys and Questionnaires; Treatment Outcome; Viral Load | 2012 |
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Administration Schedule; Female; Follow-Up Studies; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Male; Nevirapine; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load | 2012 |
Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals.
Topics: Adult; Alkynes; Anti-HIV Agents; Anticoagulants; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Drug Interactions; Female; HIV Seropositivity; Humans; International Normalized Ratio; Lopinavir; Male; Medication Adherence; Patient-Centered Care; Retrospective Studies; Ritonavir; Thromboembolism; Treatment Outcome; United States; Venous Thrombosis; Warfarin | 2012 |
[A case of vitiligo occurring after initiation of antiretroviral treatment and disappearing during this treatment: autoimmune IRIS syndrome?].
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Follow-Up Studies; HIV Seropositivity; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Male; Viral Load; Vitiligo; Zidovudine | 2012 |
[Assessment of adherence to antiretroviral: role of determination of plasma levels of non nucleosides anologues].
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Female; HIV Seropositivity; Humans; Male; Nevirapine; Oxazines; Patient Compliance; Reproducibility of Results; Self-Assessment; Surveys and Questionnaires | 2003 |
Failure of treatment of tuberculous adenitis due to an unexpected drug interaction with rifabutin and efavirenz.
Topics: Adult; Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Interactions; HIV Seropositivity; Humans; Male; Oxazines; Rifabutin; Treatment Failure; Tuberculosis, Lymph Node | 2004 |
Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring.
Topics: Alkynes; Benzoxazines; Cyclopropanes; HIV Infections; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Oxazines; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Viral Load | 2005 |
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients.
Topics: Adult; Alkynes; Alleles; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Female; Genotype; HIV Infections; HIV Seropositivity; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Nevirapine; Odds Ratio; Oxazines; Oxidoreductases, N-Demethylating; Pharmacogenetics; Polymorphism, Genetic; Protein Isoforms; Regression Analysis; Time Factors | 2005 |
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Seropositivity; Humans; Longitudinal Studies; Lopinavir; Male; Middle Aged; Oxazines; Pyrimidinones; Retrospective Studies; Ritonavir | 2005 |
Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced HIV-positive individuals.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Follow-Up Studies; HIV Seropositivity; HIV-1; Humans; Linear Models; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome | 2006 |
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Black People; Cholesterol; Cross-Sectional Studies; Cyclopropanes; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; Fasting; Female; Hispanic or Latino; HIV Infections; HIV Protease Inhibitors; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Indinavir; Lamivudine; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Multivariate Analysis; Nelfinavir; Nevirapine; Organophosphonates; Ritonavir; Stavudine; Tenofovir; Triglycerides; United States; White People | 2007 |
Gynaecomastia without lipodystrophy in HIV-1-seropositive patients on efavirenz: an alternative hypothesis.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Gynecomastia; HIV Seropositivity; HIV-1; Humans; Male; Oxazines; RNA, Viral | 2002 |
Efavirenz-induced skin eruption and successful desensitization.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Desensitization, Immunologic; Drug Hypersensitivity; Exanthema; HIV Seropositivity; Humans; Male; Oxazines | 2002 |